中国动脉粥样硬化网 >> 网站地图 >> 第97页:
http://www.sinoas.com/SiteMap/Article002.htm
  • 大部分脑卒中患者的高血压都未得到恰当的治疗Most Stroke Patients Are Treated Inappropriately for Hypertension
  • 房颤病人越来越需要抗凝治疗来预防脑卒中The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation.
  • 饮食模式影响女性卒中风险Dietary Patterns Affect Stroke Risk in Women
  • 高血压患者轻度缺血性脑卒中早期使用氯沙坦对全脑和脑局灶灌注及肾功能的影响The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke.
  • 他汀类药物对卒中幸存者有益Statins Can Benefit Stroke Survivors
  • 美国卒中学会第２９届国际会议
  • 血液标记物可协助诊断急性卒中Blood Markers May Help Diagnose Acute Stroke
  • 在糖尿病预防方面ARB是否胜过CCB?ARB beats CCB in diabetes prevention?
  • 极高危的糖尿病患者极难达到NCEP的胆固醇目标Reaching NCEP Cholesterol Goals Extremely Difficult in Very-High-Risk Diabetics
  • 糖尿病患者应用紫杉醇涂层支架有效Paclitaxel-Eluting Stents Effective in Diabetics
  • 抗糖尿病药物可降低血管的弹性Antidiabetic Agents Could Decrease Vessel Elasticity
  • 糖尿病与不同的卒中特征密切相关Diabetes Linked to Distinct Stroke Characteristics
  • 药学服务降低了2型糖尿病患者的危险因素Pharmaceutical Care Reduces Risk Factors in Type 2 Diabetes
  • 血浆糖化蛋白水平可反映糖尿病的短期控制情况Glycated Plasma Protein Levels Reflect Short-Term Diabetes Control
  • 非诺贝特可延缓糖尿病患者进展到微白蛋白尿Fenofibrate Slows Progression to Microalbuminuria in Diabetic Patients
  • 他汀可消除糖尿病患者PCI术后发生主要不良冠脉事件的危险Statins Remove Diabetic M ACE Risk Post-PCI
  • 糖尿病患者未充分控制其发生冠心病的危险Diabetes CHD Risk Management Suboptimal
  • 脂联素可降低糖尿病男性患者的心脏病危险Adiponectin May Cut Heart Disease Risk in Diabetic Men
  • 坚持他汀治疗在糖尿病血脂异常达标中处于中心地位Statin Adherence Central to Diabetic Dyslipidemia Goal Attainment
  • OxLDL抗体可反映晚期糖尿病的动脉粥样硬化OxLDL Antibodies Reflect Advanced Diabetic Atherosclerosis
  • 糖尿病女性在冠心病预防中处于不利位置Diabetic Women Disadvantaged in CHD Prevention
  • 血管紧张素受体拮抗剂可改善糖尿病患者的肾血流Angiotensin Receptor Blockade Improves Renal Blood Flow in Diabetics
  • 美托洛尔控释片/缓释片在合并糖尿病的慢性心力衰竭患者中应用的有效性、安全性和耐受性：来自MERIT-HF试验的经验Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF
  • 糖尿病患者进行PCI的效果差“反映了灌注异常”Poor Diabetic PCI Outcomes Reflect Abnormal Perfusion
  • 糖尿病女性的心脏死亡危险高于糖尿病男性患者Risk of Cardiac Death Higher in Diabetic Women Than Diabetic Men
  • 糖尿病高血压患者加用坎地沙坦对赖诺普利的疗效没有特别的帮助Candesartan No Extra Aid to Lisinopril in Diabetic Hypertension
  • ACE抑制剂可改善血压正常糖尿病患者的动脉弹性ACE Inhibitors Improve Arterial Elasticity in Normotensive Diabetics
  • 维生素E未能改善糖尿病患者的内皮或左心室功能Vitamin E Unlikely to Improve Endothelial or LV Function in Diabetics
  • 脂联素对1型糖尿病患者的冠心病有“保护作用”Adiponectin CAD Protective in Type 1 Diabetes
  • 心血管危险因素可加重糖尿病性神经病变CV Risk Factors Hasten Diabetic Neuropathy
  • 糖尿病血脂异常的治疗最好有严格目标Stringent Targets Best for Diabetic Dyslipidemia
  • 早期利尿剂治疗对伴有单纯收缩期高血压的糖尿病患者有益Early Diuretic Therapy Benefits Diabetics With Isolated Systolic Hypertension
  • 在合并或不合并糖尿病的单纯性收缩期高血压的患者中基于利尿剂的治疗对致死性事件的长期效果Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes
  • 治疗糖尿病的药物“与心衰无关”Antidiabetic Drugs Not Linked With HF
  • 糖尿病患者置入支架的结果不受球囊预扩张的影响Diabetic Stenting Outcome Unaffected by Balloon Predilatation
  • HDL胆固醇和甘油三酯可预测糖尿病患者发生冠心病的危险HDL Cholesterol and Triglycerides Drive CAD Risk in Diabetics
  • QT间期异常可预测糖尿病患者的心脏死亡危险QT Abnormalities Predict Risk of Cardiac Death in Diabetics
  • 伴有心衰并应用胰岛素治疗的糖尿病患者死亡率飙升Mortality Boosted in Insulin-Using Diabetics With Heart Failure
  • 硫酸脱氢表雄酮（DHEA-S）可能是糖尿病患者血管异常的标记物DHEA-S May Be Marker of Vascular Abnormalities in Diabetics
  • 女性和中青年糖尿病患者应用阿司匹林不充分Aspirin Underused by Women and Younger Adults With Diabetes
  • 肾小球滤过率降低可预测糖尿病患者的心脏事件Reduced glomerular filtration rate predicts cardiac events in diabetics
  • 糖尿病患者置入冠脉支架的危险“主要存在于女性”Diabetic stenting risk mainly in women
  • 他汀类不改变糖尿病患者的颈动脉内-中层厚度Statins Do Not Alter Carotid Intima-Media Thickness in Diabetics
  • 糖尿病患者心血管疾病（CVD）的事件发生率降低Diabetes CVD event rates falling
  • ACE抑制剂对糖尿病肾病的治疗的效果可能最佳ACE Inhibitors May Be Best for Diabetic Nephropathy
  • [AHA2004] 阿昔单抗可减少糖尿病患者经皮冠脉介入术后的再狭窄Abciximab reduces diabetic restenosis after coronary intervention
  • 严格的血压控制可降低糖尿病视网膜病变的危险Tight BP Control May Reduce Risk of Diabetic Retinopathy
  • ARB延缓糖尿病肾病进展ARB protects against diabetic nephropathy progression
  • 糖尿病病人发生心脏病的危险与低铬相关Low Chromium Linked to Heart Disease Risk in Patients With Diabetes
  • 糖尿病危及女性心脏病患者Diabetes Dangerous in Women With Heart Disease
  • 肥胖和体适能水平与心血管危险及糖尿病之间的关系Relationship of Obesity and Fitness Level to Cardiovascular Risk and Diabetes
  • 对糖尿病肾病的治疗可能ACE抑制剂的效果最佳ACE inhibitors may be best for diabetic nephropathy
  • 单纯饮食治疗糖尿病引发多种并发症Diabetics Treated With Diet Only Have More Complications
  • 血压，胆固醇是许多糖尿病病人的问题Blood Pressure,Cholesterol Are Problems for Many Diabetics
  • 1型糖尿病患者早期出现心室肥大Ventricular Hypertrophy Appears Early in Type 1 Diabetes
  • 20%的无症状糖尿病患者存在静息性心肌缺血Twenty Percent of Patients With Asymptomatic Diabetes Have Silent Myocardial Ischemia
  • 糖尿病儿童面临心血管疾病的危险Diabetic Kids Headed for Cardiovascular Trouble
  • 他汀治疗对糖尿病患者心血管疾病及脑卒中的一级预防有效Statin Therapy Effective for Primary Prevention of CVD, Stroke in Diabetics
  • 2型糖尿病患者充血性心衰发生率高于既往估测值Incidence of CHF in Type 2 Diabetics Higher Than Previously Estimated
  • ACEI提高2型糖尿病患者的生存率ACE Inhibitors Improve Survival in Type 2 Diabetes
  • 罗格列酮可以抑制非糖尿病冠心病患者的血小板活性Rosiglitazone Curbs Platelets in Nondiabetics With Coronary Artery Disease
  • 餐后和空腹血糖在控制2型糖尿病中的临床意义Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
  • 类阿司匹林药物有望能够安全有效的治疗2型糖尿病药物Aspirin-Like Treatment May Be Safe, Effective for Type 2 Diabetes
  • 苯扎贝特有可能减少罹患2型糖尿病的风险Bezafibrate May Reduce Type 2 Diabetes Risk
  • 多数2型糖尿病患者应该服用他汀类药物Many Type 2 Diabetics Should Take Statins
  • 积极的关照有助提升糖尿病病人的整体健康水平Aggressive Care Boosts Diabetics Overall Health
  • 阿卡波糖降低糖尿病患者心脏病发作风险
  • 糖尿病患者的危险因素控制仍是一道难题Risk control still a problem for diabetics
  • 严格的血糖控制对合并糖尿病的心脏疾病患者至关重要Strict Blood Sugar Control Key for Diabetic Heart Patients
  • L-精氨酸乳霜可改善糖尿病足的血流及温度
  • 医生和患者需要倾情合作共同治疗糖尿病——在改进疾病治疗的目标和战略上达成一致Doctor, Patient Need to Manage Diabetes Together
  • 阿司匹林在糖尿病中的预防效果尚不明确Prophylactic Effect of Aspirin Unclear in Diabetics
  • 桂皮可改善2型糖尿病患者的血糖和血脂水平Cinnamon May Improve Glucose, Lipid Control in Type 2 Diabetics
  • 国际动脉粥样硬化会议：匹格列酮降低2型糖尿病患者的心血管风险Pioglitazone Improves Cardiovascular Risk Profile of Patients With Type 2 Diabetes
  • 对于患有糖尿病神经病变和高血压的患者伊贝沙坦比氨氯地平更为有效Irbesartan More Effective than Amlodipine in Patients with Diabetic Neuropathy and Hypertension
  • 炎性标记物水平升高可预测2型糖尿病患者的心血管性死亡Elevated Inflammatory Markers Predict Cardiovascular Death For Type 2 Diabetes Patients
  • 空腹血糖升高可预测非糖尿病的AMI 患者的30天死亡率High Fasting Glucose Predictive of 30-Day Death in Nondiabetic AMI Patients
  • 一年的临床研究结果证实了Taxus在糖尿病患者中的疗效One-Year Trial Results Confirm Efficacy of Taxus in Diabetic Patients
  • 磷酸肌酸缺乏的胍乙酸N-甲基转移酶基因敲除小鼠对心脏缺血再灌注损伤肌力储备下降,易感性增高
  • 生长因子刺激缺血后损伤心肌的旁分泌，提高胚胎干细胞植入及向宿主特异性分化
  • 低钠血症提高了心衰恶化的住院患者短期内的死亡率
  • 肥厚性梗阻型心肌病酒精间隔消融后左室重构早期产生及发展
  • 1型糖尿病患者加强血糖的控制对炎性标记物的影响---DCCT研究
  • 通过心肌内植入经体外TGF-ß预处理的骨髓干细胞治疗梗死心肌的再生结果
  • P38/MAPK调节心脏炎症因子介导的心肌细胞及细胞外基质的重构
  • 血管平滑肌细胞中血管紧张素II通过非TGF-ß依赖途径激活Smad通路
  • 对窦房结功能障碍起搏器植入患者的临床试验表明QRS间期延长与死亡相关
  • 可卡因使用者中冠状动脉血管瘤发生率增高
  • 活动性心内膜炎二尖瓣修复的预后情况
  • 心梗后缺乏雌激素ß 受体的雌性鼠左室的复极化延长及心室的自律性降低


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
    26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
    51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75
    76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 [97] 98 99 100
    101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125
    126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150
    151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175
    176 177 178 179 180 181 182